原发性双侧肾上腺大结节样增生伴脑膜瘤患者基因突变1例

刘晓龙; 王祥众; 胡睿; 李黎明; 刘晓强

doi:10.13201/j.issn.1001-1420.2020.03.020

原发性双侧肾上腺大结节样增生伴脑膜瘤患者基因突变1例

- 天津医科大学总医院泌尿外科(天津, 300052)
基金项目:
赵以成医学科学基金(No:ZYYFY2018031)

详细信息

通讯作者: 刘晓强,E-mail:13820915038@163.com

中图分类号: R699.3

收稿日期: 2019-10-16

Corresponding author: , E-mail: 13820915038@163.com

Received Date: 16 October 2019

摘要

- 原发性双侧肾上腺大结节样增生 /
- 库欣综合征 /
- ARMC5 /
- 脑膜瘤

HTML全文

参考文献(16)

[1]	Liu Q,Tong D,Xu J,et al.A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia:a case report[J].BMC Med Genet,2018,19(1):49.
[2]	De Venanzi A,Alencar G A,Bourdeau I,et al.Primary bilateral macronodular adrenal hyperplasia[J].Curr Opin Endocrinol Diabetes Obes,2014,21(3):177-184.
[3]	Vezzosi D,Cartier D,Regnier C,et al.Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors[J].Eur J Endocrinol,2007,156(1):21-31.
[4]	Assie G,Libe R,Espiard S,et al.ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome[J].N Engl J Med,2013,369(22):2105-2114.
[5]	Elbelt U,Trovato A,Kloth M,et al.Molecular and clinical evidence for an ARMC5 tumor syndrome:concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma[J].J Clin Endocrinol Metab,2015,100(1):E119-E128.
[6]	Faucz F R,Zilbermint M,Lodish M B,et al.Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5(ARMC5)gene:a clinical and genetic investigation[J].J Clin Endocrinol Metab,2014,99(6):E1113-E1119.
[7]	Espiard S,Drougat L,Libe R,et al.ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia:Clinical and Functional Consequences[J].J Clin Endocrinol Metab,2015,100(6):E926-E935.
[8]	Berthon A,Faucz F,Bertherat J,et al.Analysis of ARMC5 expression in human tissues[J].Mol Cell Endocrinol,2017,441:140-145.
[9]	Alencar GA,Lerario AM,Nishi MY,et al.ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia[J].J Clin Endocrinol Metab,2014,99(8):E1501-E1509.
[10]	Lebrethon MC,Avallet O,Reznik Y,et al.Food-dependent Cushing's syndrome:characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients[J].J Clin Endocrinol Metab,1998,83(12):4514-4519.
[11]	Lacroix A,Baldacchino V,Bourdeau I,et al.Cushing's syndrome variants secondary to aberrant hormone receptors[J].Trends Endocrinol Metab,2004,15(8):375-382.
[12]	Lacroix A,Ndiaye N,Tremblay J,et al.Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome[J].Endocr Rev,2001,22(1):75-110.
[13]	Bourdeau I,D'Amour P,Hamet P,et al.Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome[J].J Clin Endocrinol Metab,2001,86(11):5534-5540.
[14]	Mircescu H,Jilwan J,N'Diaye N,et al.Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?[J].J Clin Endocrinol Metab,2000,85(10):3531-3536.
[15]	Bertagna X,Groussin L,Luton J P,et al.Aberrant receptor-mediated Cushing's syndrome[J].Horm Res,2003,59 Suppl 1:99-103.
[16]	Louiset E,Duparc C,Young J,et al.Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia[J].N Engl J Med,2013,369(22):2115-2125.